We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $43.3B
1-Year Est. Return 29.3%
This Fund
S&P 500
This Quarter Est. Return
+17.09%
1 Year Est. Return
+29.3%
3 Year Est. Return
+83.12%
5 Year Est. Return
+90.93%
10 Year Est. Return
+282.52%
AUM
$43.3B
AUM Growth
+$4.47B
Cap. Flow
-$120M
Cap. Flow %
-0.28%
Top 10 Hldgs %
19.72%
Holding
4,210
New
286
Increased
1,913
Reduced
1,499
Closed
436

Sector Composition

Rank Sector Weight
1 Technology 13.13%
2 Financials 4.34%
3 Industrials 3.63%
4 Consumer Discretionary 3.11%
5 Communication Services 2.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PSCE icon
4026
Invesco S&P SmallCap Energy ETF
PSCE
$95.8M
-36,412
Closed -$2.22M
PSH icon
4027
PGIM Short Duration High Yield ETF
PSH
$170M
-8,760
Closed -$434K
PSMT icon
4028
Pricesmart
PSMT
$5.81B
-6,185
Closed -$931K
PSTV icon
4029
Plus Therapeutics
PSTV
$25.7M
-538
Closed -$2K
PY icon
4030
Principal Exchange-Traded Funds Principal Value ETF
PY
$235M
-16,281
Closed -$838K
PZG icon
4031
Paramount Gold Nevada
PZG
$96.1M
-238,599
Closed -$396K
PZT icon
4032
Invesco New York AMT-Free Municipal Bond ETF
PZT
$138M
-19,375
Closed -$428K
QDEC icon
4033
FT Vest Growth-100 Buffer ETF December
QDEC
$682M
-84,198
Closed -$2.65M
QID icon
4034
ProShares UltraShort QQQ
QID
$288M
-48,524
Closed -$1.1M
QJUN icon
4035
FT Vest Growth-100 Buffer ETF June
QJUN
$643M
-109,536
Closed -$3.42M
QMAR icon
4036
FT Vest Growth-100 Buffer ETF March
QMAR
$559M
-138,578
Closed -$4.66M
QNCX icon
4037
Quince Therapeutics
QNCX
$17.5M
-76
Closed -$2K
QSPT icon
4038
FT Vest Nasdaq-100 Buffer ETF September
QSPT
$618M
-91,562
Closed -$2.8M
RWLC
4039
Rayliant NxtGen Multifactor US Equity ETF
RWLC
$96.8M
-8,718
Closed -$278K
RDVT icon
4040
Red Violet
RDVT
$889M
-5,926
Closed -$205K
REW icon
4041
Proshares UltraShort Technology
REW
$3.53M
-34,363
Closed -$859K
REZI icon
4042
Resideo Technologies
REZI
$5.34B
-6,562
Closed -$221K
RMT
4043
Royce Micro-Cap Trust
RMT
$735M
-39,192
Closed -$443K
ROE icon
4044
Astoria US Quality Kings ETF
ROE
$262M
-27,333
Closed -$968K
RSPD icon
4045
Invesco S&P 500 Equal Weight Consumer Discretionary ETF
RSPD
$313M
-4,355
Closed -$233K
RTO icon
4046
Rentokil
RTO
$14.4B
-7,206
Closed -$227K
RVSNW icon
4047
Rail Vision Ltd Warrant
RVSNW
$1.09M
$0 ﹤0.01%
28,832
-29,658
-51% -$777
RVT icon
4048
Royce Value Trust
RVT
$2.21B
-120,196
Closed -$2M
RWM icon
4049
ProShares Short Russell2000
RWM
$132M
-26,117
Closed -$424K
SAUG icon
4050
FT Vest US Small Cap Moderate Buffer ETF August
SAUG
$110M
-26,141
Closed -$673K

Similar funds

Cambridge Investment Research Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, Cambridge Investment Research Advisors held 4,210 positions worth $43.3B, up 12% from $38.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Cambridge Investment Research Advisors's Q2 2026 filing shows 286 new, 1,913 increased, 1,499 reduced and 436 closed positions. Its largest new stake was SpaceX: 259,405 shares worth $44.3M. The largest sale was FT Vest Fund of Buffer ETFs, an estimated $111M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.

  • Cambridge Investment Research Advisors's largest Q2 2026 buy was SpaceX: 259,405 shares worth $44.3M.
  • Cambridge Investment Research Advisors added most to State Street SPDR Portfolio S&P 500 ETF in Q2 2026, an estimated $126M increase.
  • Cambridge Investment Research Advisors's biggest Q2 2026 reduction was JPMorgan Ultra-Short Income ETF, cutting an estimated $73.5M.
  • Cambridge Investment Research Advisors fully exited FT Vest Fund of Buffer ETFs in Q2 2026, selling an estimated $111M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $43.3B portfolio in Q2 2026.
  • Cambridge Investment Research Advisors opened 286 new positions and closed 436 in Q2 2026.
  • Cambridge Investment Research Advisors's portfolio value rose 12% quarter-over-quarter to $43.3B.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.